Madrigal Pharmaceuticals
Dr. Waltermire brings proven expertise in all aspects of chemistry, manufacturing and control (CMC), as well as experience in manufacturing new commercial products. Most recently, Dr. Waltermire served as Senior Vice President, CMC at VenatoRx. From 1988 to 2020, Dr. Waltermire held positions of increasing responsibility at Bristol-Myers Squibb (BMS) and Dupont Pharmaceutical Company, including Vice President Chemical and Synthetic Development at BMS.
This person is not in any teams
This person is not in any offices
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.